About
AI-derived brain biomarkers for therapeutic matching
Areas of Focus
Categories
DiagnosticsSmall Molecule PharmaceuticalAI FocusedBiotech
Clinical Trials (25)
View allTotal Trials
25
As Lead Sponsor
17
As Collaborator
8
Total Enrollment
2,829
By Phase
PHASE2: 13NA: 5PHASE4: 2PHASE1: 3
By Status
COMPLETED: 12RECRUITING: 5WITHDRAWN: 4NOT_YET_RECRUITING: 2ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline25 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07217665Collaborator
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
PHASE2Not yet recruiting
146 participants
Started: Dec 1, 2025 · Completed: Jul 31, 2029
NCT07167966Collaborator
Alzheimer's Tau Platform: Regimen A - AADvac1
PHASE2Not yet recruiting
375 participants
Started: Nov 30, 2025 · Completed: Aug 31, 2028
NCT06656416Lead Sponsor
ALTO-100 in Bipolar Disorder With Depression (BD-D)
PHASE2Recruiting
200 participants
Started: Oct 2, 2024 · Completed: Oct 31, 2026
NCT06502964Lead Sponsor
Study of ALTO-101 in Patients With Schizophrenia
PHASE2Recruiting
82 participants
Started: Jun 11, 2024 · Completed: Nov 30, 2025
NCT06391593Lead Sponsor
PD, PK, and Safety of ALTO-203 in Patients With MDD
PHASE2Completed
69 participants
Started: Mar 25, 2024 · Completed: Apr 21, 2025
Locations (1)
Headquarters
Mountain View, CA, United States
Map
Loading map...